120 related articles for article (PubMed ID: 20403382)
1. Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults.
Molton J; Smith C; Chaytor S; Maple P; Brown K; Johnson M; Geretti AM
J Infect; 2010 Jul; 61(1):73-80. PubMed ID: 20403382
[TBL] [Abstract][Full Text] [Related]
2. Apropos "Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults".
Arya SC; Agarwal N
J Infect; 2010 Oct; 61(4):353. PubMed ID: 20691726
[No Abstract] [Full Text] [Related]
3. Immunizations for HIV-infected adults: indications, timing, and response.
Spach DH
Top HIV Med; 2006 Dec-2007 Jan; 14(5):154-8. PubMed ID: 17237556
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
[TBL] [Abstract][Full Text] [Related]
5. High need for MMR vaccination in HIV infected adults in Austria.
Grabmeier-Pfistershammer K; Poeppl W; Herkner H; Touzeau-Roemer V; Huschka E; Rieger A; Burgmann H
Vaccine; 2014 Oct; 32(45):6020-3. PubMed ID: 25203449
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
7. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
Buxbaum S; Doerr HW; Allwinn R
Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
[TBL] [Abstract][Full Text] [Related]
9. Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland.
Kerr C; Kelleher M; Coughlan S; Crowley B; O'Reilly EJ; Bergin C
BMC Infect Dis; 2022 Jun; 22(1):582. PubMed ID: 35768790
[TBL] [Abstract][Full Text] [Related]
10. Vaccination in Brazilian HIV-infected adults: a cross-sectional study.
Ho YL; Enohata T; Lopes MH; De Sousa Dos Santos S
AIDS Patient Care STDS; 2008 Jan; 22(1):65-70. PubMed ID: 18095834
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and immunization history of selected vaccine preventable diseases in medical students.
Baer G; Bonhoeffer J; Schaad UB; Heininger U
Vaccine; 2005 Mar; 23(16):2016-20. PubMed ID: 15734076
[TBL] [Abstract][Full Text] [Related]
13. Attitudes regarding occupational vaccines and vaccination coverage against vaccine-preventable diseases among healthcare workers working in pediatric departments in Greece.
Maltezou HC; Lourida A; Katragkou A; Grivea IN; Katerelos P; Wicker S; Syrogiannopoulos GA; Roilides E; Theodoridou M
Pediatr Infect Dis J; 2012 Jun; 31(6):623-5. PubMed ID: 22333705
[TBL] [Abstract][Full Text] [Related]
14. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
[TBL] [Abstract][Full Text] [Related]
15. [Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia].
Hannachi N; Marzouk M; Harrabi I; Ferjani A; Ksouri Z; Ghannem H; Khairi H; Hidar S; Boukadida J
Bull Soc Pathol Exot; 2011 Feb; 104(1):62-7. PubMed ID: 21243459
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated herpes zoster vaccine for HIV-infected adults.
Shafran SD
HIV Med; 2016 Apr; 17(4):305-10. PubMed ID: 26315285
[TBL] [Abstract][Full Text] [Related]
17. Managing vaccines: defining the remit of primary care and specialist HIV clinics in the delivery of immunization to individuals with HIV infection.
Quinn KJ; McCarty EJ; Quah SP; Emerson CR; Donnelly CM
Int J STD AIDS; 2012 Feb; 23(2):136-7. PubMed ID: 22422690
[TBL] [Abstract][Full Text] [Related]
18. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
19. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
20. Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland.
Myers C; Posfay-Barbe KM; Aebi C; Cheseaux JJ; Kind C; Rudin C; Nadal D; Siegrist CA; ;
Pediatr Infect Dis J; 2009 Nov; 28(11):996-1001. PubMed ID: 19820427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
